Skip to main content

The Arachidonate Cascade and Mouse Skin Tumor Promotion

  • Conference paper
Book cover Prostaglandins in Cancer Research

Part of the book series: Proceedings in Life Sciences ((LIFE SCIENCES))

Abstract

The observations of Janoff et al. (1970) and Marks et al. (1982) that the application of the tumor promoter TPA induces cytotoxicity, inflammation, and vascular permeability changes provided the basis for inquiry into the involvement of arachidonate metabolites in such manifestations and in the tumor promotion process. Mouse skin is one of the more commonly used organs in experimental carcinogenesis studies and has proved to be one of the best model systems for studying the multistage nature of carcinogenesis (Berenblum and Shubik 1947; Slaga et al. 1980a, 1981a). Skin tumors in mice can be readily induced by the sequential application of a subthreshold dose of a carcinogen (initiation stage) followed by repetitive treatment with a noncarcinogenic tumor promoter (promotion stage). Promotion is most often accomplished by using 12-O-tetradecanoyl phorbol-13-acetate (TPA), although a variety of agents have been identified as skin tumor promoters, including benzoyl peroxide, anthralin, and dihydroteleocidin B (Slaga 1984). Promotion can be further subdivided such that the appropriate sequential use of incomplete or partial promoters such as the calcium ionophore A-23187 (first stage promoter) and mezerein (second stage) can supplant the use of a complete promoter.

This work wa supported by NIH Grants CA-34443 and CA-42211.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 84.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 109.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Abbreviations

TPA:

12-O-tetradecanoyl phorbol-13-acetate

ODC:

ornithine decarboxylase

PGs:

prostaglandins

NDGA:

nordihydroguaiaretic acid

HETE:

hydroxyeicosatetraenoic acid

HPETE:

hydroperoxyeicosatetraenoic acid

SOD:

superoxide dismutase

CuDIPS = Cu(II)(3,4:

diisopropyl salicylic acid)2

CL:

chemiluminescence.

References

  • Belman S, Troll W (1972) The inhibition of croton oil-promoted mouse skin tumorigenesis by steroid hormones. Cancer Res 32: 450–454

    PubMed  CAS  Google Scholar 

  • Berenblum I, Shubik P (1947) A new quantitative approach to the study of the stages of chemical carcinogenesis in the mouse skin. Br J Cancer 1:383 –391

    Article  PubMed  CAS  Google Scholar 

  • Bresnick E, Meunier P, Lamden M (1979) Epidermal prostaglandins after topical application of a tumor promoter. Cancer Lett 7: 121–125

    Article  PubMed  CAS  Google Scholar 

  • Bors W, Saran M, Michel C (1983) Assays of oxygen radicals: methods and mechanisms. In: Oberley LW (ed) Superoxide Dismutase, vol 2. CRC Boca Raton, pp 31–63

    Google Scholar 

  • Danaika J, Ichikawa A, Okada M, Tomita A (1984) Calcium dependency of inhibition by arachidonic acid of Compound 48/80-induced histamine release from mast cells. Biochem Pharmacol 33: 1653–1659

    Article  Google Scholar 

  • DeChatelet LR, McCall CE, McPhail LC, Johnston RB (1974) Superoxide dismutase activity in leukocytes. J Chem Invest 53: 1197–1201

    Article  Google Scholar 

  • Fischer SM (1983) The role of prostaglandins in tumor promotion. In: Slaga TJ (ed) Mechanisms of Tumor Promotion, vol II. Tumor Promotion and Skin Carcinogenesis. CRC Boca Raton, pp 113–126

    Google Scholar 

  • Fischer SM, Adams LA (1985) Tumor promoter-induced chemiluminescence in mouse epidermal cells is inhibited by several inhibitors of arachidonic acid metabolism. Cancer Res 45:3130– 3136

    PubMed  CAS  Google Scholar 

  • Fischer SM, Slaga TJ (1982) Modulation of prostaglandin synthesis and tumor promotion. In: Powles TJ et al. (eds) Prostaglandins and Cancer First International Conf. Alan R Liss, New York, pp 255–264

    Google Scholar 

  • Fischer SM, Gleason GL, Bohrman JS, Slaga TJ (1980a) Prostaglandin modulation of phorbol ester skin tumor promotion. Carcinogenesis (Lond) 1: 245–248

    Article  CAS  Google Scholar 

  • Fischer SM, Gleason GL, Mills GD, Slaga TJ (1980b) Indomethacin enhancement of TPA tumor promotion in mice. Cancer Lett 10: 343–350

    Article  PubMed  CAS  Google Scholar 

  • Fischer SM, Mills GD, Slaga TJ (1982) Inhibition of mouse skin tumor promotion by several inhibitors of arachidonic acid metabolism. Carcinogenesis (Lond) 3: 1243–1245

    Article  CAS  Google Scholar 

  • Fischer SM, Mills GD, Slaga TJ (1983) In: Samuelsson B, Paoletti R, Ramwell P (eds) Adv Prostaglandin, Thromboxane and Leukotriene Research, vol 12. Raven, New York, pp 309–312.

    Google Scholar 

  • Fischer SM, Baldwin JK, Adams LM (1985) Phospholipase C mimics tumor-promoter induced chemiluminescence in murine epidermal cells. Biochem Biophys Res Commun 131: 1103–1108

    Article  PubMed  CAS  Google Scholar 

  • Fischer SM, Baldwin JK, Adams LM (1986) Effects of anti-promoters and strain of mouse on tumor promoter-induced oxidants in murine epidermal cells. Carcinogenesis 7: 915–918

    Article  PubMed  CAS  Google Scholar 

  • Fürstenberger G, Marks F (1982) Studies on the role of prostaglandins in the induction of cell proliferation and hyperplasia and in tumor promotion in mouse skin. In: Hecker E et al. (eds) Symp on Cocareinogenesis and Biological Effects on Tumor Promoters. Raven, New York, pp 325–330

    Google Scholar 

  • Fürstenberger G, Marks F (1985) Prostaglandins, epidermal hyperplasia and skin-tumor promotion. In: Fischer SM, Slaga TJ (eds) Arachidonic acid metabolism and tumor promotion, Martinus Nijhoff, Boston, pp 49–72

    Chapter  Google Scholar 

  • Gryglewski RJ (1979) Effects of anti-inflammatory steroids on arachidonate cascade. In: Weissman G et al. (eds) Adv Inflammation Res, vol 1. Raven, New York, p 505

    Google Scholar 

  • Hamberg M, Samuelsson B (1974) Prostaglandin endoperoxides. Novel transformations of arachidonic acid in human platelets. Proc Natl Acad Sci USA 71: 3400–3404

    Article  PubMed  CAS  Google Scholar 

  • Hammarström S, Hamberg M, Samuelsson B, Duell E, Stawiski M, Vorhees J J (1975) Increased concentrations of nonesterifled arachidonic acid, 12L-hydroxy 5,8,10,14-eicosatetraenoic acid, prostaglandin E2 and prostaglandin F2α in epidermis of psoriasis. Proc Natl Acad Sci USA 72: 5130–5134

    Article  PubMed  Google Scholar 

  • Hong SL, Levine L (1976) Inhibition of arachidonic acid release from cells as the biochemical action of anti-inflammatory corticosteroids. Proc Natl Acad Sci USA 73: 1730–1734

    Article  PubMed  CAS  Google Scholar 

  • Janoff A, Klassen A, Troll W (1970) Local vascular changes induced by the cocarcinogen phorbol myristate acetate. Cancer Res 30: 2568

    PubMed  CAS  Google Scholar 

  • Jeng AY, Licht U, Strickland JE, Blumberg PM (1985) Similar effects of phospholipase C and phorbol ester tumor promoters on primary mouse epidermal cells. Cancer Res 45: 5714–5721

    PubMed  CAS  Google Scholar 

  • Kato R, Nakadate T, Yamamoto S, Sugimura T (1983) Inhibition of 12-O-tetradecanoylphorbol- 13-acetate-induced tumor promotion and ornithine decarboxylase activity by quercetin: possible involvement of lipoxygenase inhibition. Carcinogenesis (Lond) 4: 1301–1035

    Article  CAS  Google Scholar 

  • Kato R, Nakadate T, Yamamoto S (1984) Involvement of lipoxygenase products of arachidonic acid in tumor-promoting activity of TPA. In: Thaler-Dao et al. (eds) Icosanoids and Cancer. Raven, New York, pp 101–113

    Google Scholar 

  • Kensler TW, Trush MA (1981) Inhibition of phorbol ester stimulated chemiluminescence in human polymorphonuclear leukocytes by retinoic acid and 5,6 epoxyretinoic acid. Cancer Res 41: 216–222

    PubMed  CAS  Google Scholar 

  • Kensler TW, Trush MA (1983) Inhibition of oxygen radical metabolism in phorbol ester-activated polymorphonuclear leukocytes by an antitumor promoting copper complex with superoxide dismutase mimetic activity. Biochem Pharmacol 32: 3485–3487

    Article  PubMed  CAS  Google Scholar 

  • Kensler TW, Bush DM, Kozumbo WJ (1983) Inhibition of tumor promotion by a biomimetic superoxide dismutase. Science 221: 75–77

    Article  PubMed  CAS  Google Scholar 

  • Kondoh H, Sato Y, Kanoh H (1985) Arachidonic acid metabolism in cultured mouse keratinocytes. J Invest Dermatol 85: 64–69

    Article  PubMed  CAS  Google Scholar 

  • Marks F, Berry DL, Bertsch S, Fürstenberger G, Richter H (1982) On the relationship between epidermal hyperproliferation and skin tumor promotion. In: Hecker E et al. (eds) Cocarcinogenesis and biological effects of tumor promoters. Raven, New York, pp 331 — 346

    Google Scholar 

  • Nakadate T, Yamamoto S, Iseki H, Sonoda S, Takemura S, Ura A, Hosoda Y, Kato R (1982) Inhibition of 12-0-tetradecanoylphorbol-13-acetate-induced tumor promotion by nordihydroguaia- retic acid, a lipoxygenase inhibitor and p-bromophenacyl bromide, a phospholipase A2 inhibitor. Gann 73: 841–843

    PubMed  CAS  Google Scholar 

  • Nishisuka Y (1984) The role of protein kinase C in cell surface signal transduction and tumour promotion. Nature 308: 693–698

    Article  Google Scholar 

  • Reiners JJ, Nesnow S, Slaga TJ (1985) Murine susceptibility to two-stage carcinogenesis is influenced by the agent used for promotion. Carcinogenesis (Lond) 5: 301 — 307

    Article  Google Scholar 

  • Schwartz JA, Viaje A, Slaga TJ, Yuspa SH, Hennings H, Lichti U (1977) Fluocinolone acetonide: A potent inhibitor of mouse skin tumor promotion and epidermal DNA synthesis. Chem Biol Interact 17: 331–347

    Article  Google Scholar 

  • Slaga TJ (1984) Mechanisms involved in two-stage carcinogenesis in mouse skin. In: Slaga T (ed) Mechanism of tumor promotion. CRC, Boca Raton, pp 1–16

    Google Scholar 

  • Slaga TJ, Fischer SM, Viaje A, Berry DL, Bracken WM, LeClerc S, Miller DL (1978) Inhibition of tumor promotion by anti-inflammatory agents: an approach to the biochemical mechanism of promotion. In: Slaga TJ, Sivak A, Boutwell RK (eds) Carcinogenesis, Mechanisms of Tumor Promotion and Cocarcinogenesis, vol 2. Raven, New York, pp 173–195

    Google Scholar 

  • Slaga TJ, Fischer SM, Nelson K, Gleason GL (1980a) Studies on the mechanism of skin tumor promotion: evidence for several stages in promotion. Proc Natl Acad Sci USA 77:3659– 3663

    Article  CAS  Google Scholar 

  • Slaga TJ, Fischer SM, Weeks CE, Klein-Szanto AJP (1980b) Multistage chemical carcinogenesis. In: Seije M, Bernstein IA (eds) Biochemistry of Normal and Abnormal Epidermal Differentiation. Univ Tokyo Press, Tokyo, pp 193–218

    Google Scholar 

  • Slaga TJ, Klein-Szanto AJP, Fischer SM, Weeks CE, Nelson K, Major S (1980c) Studies on the mechanism of action of anti-tumor promoting agents: Their specificity in two-stage promotion. Proc Natl Acad Sci USA 77: 2251–2254

    Article  PubMed  CAS  Google Scholar 

  • Slaga TJ, Fischer SM, Weeks CE, Klein-Szanto AJP (1981a) In: Hodgson E, Bend JR, Philpot RM (eds) Rev Biochem Tox. Elsevier/North Holland, New York, pp 231–282

    Google Scholar 

  • Slaga TJ, Klein-Szanto AJP, Triplett LL, Yotti LP (1981b) Skin tumor-promoting activity of benzoyl peroxide, a widely used free radical-generating compound. Science 213: 1023–1025

    Article  PubMed  CAS  Google Scholar 

  • Slaga TJ, Solanki V, Logani M (1983) Studies on the mechanism of action of antitumor promoting agents: Suggestive evidence for the involvement of free radicals in promotion. In: Radio protectors and anticarcinogens. Academic Press, London, pp 471–485

    Google Scholar 

  • Smith RL, Weidemann MJ (1980) Reactive oxygen production associated with arachidonic acid metabolism by peritoneal macrophages. Biochem Biophys Res Commun 97: 973–980

    Article  PubMed  CAS  Google Scholar 

  • Solanki V, Rana RS, Slaga TJ (1981) Diminution of mouse superoxide dismutase and catalase activities by tumor promoters. Carcinogenesis (Lond) 2: 1141–1146

    Article  CAS  Google Scholar 

  • Trash MA, Wilson ME, Van Dyke K (1978) The generation of chemiluminescence by phagocytic cells. Methods Enzymol 57: 462–494

    Article  Google Scholar 

  • Verma AK, Rice HM, Boutwell RK (1977) Prostaglandins and skin tumor promotion: Inhibition of tumor promoter-induced ornithine decarboxylase activity in epidermis by inhibitors of prostaglandin synthesis. Biochem Biophys Res Commun 79: 1160–1166

    Article  PubMed  CAS  Google Scholar 

  • Verma AK, Ashendel CL, Boutwell RK (1980) Inhibition by prostaglandin synthesis inhibitors of the induction of epidermal ornithine decarboxylase activity, the accumulation of prostaglandins and tumor promotion caused by 12-0-tetradecanoyl-phorbol-13-acetate. Cancer Res 40: 308–315

    PubMed  CAS  Google Scholar 

  • Witz G, Goldstein BD, Amdruso M, Stone DS, Troll W (1980) Retinoid inhibition of superoxide anion radical production by human polymorphonuclear leukocytes stimulated with tumor pro-moters. Biochem Biophys Res Commun 97: 883–888

    Article  PubMed  CAS  Google Scholar 

  • Yotti LP, Chang CC, Trosko JE (1979) Elimination of metabolic cooperation in Chinese hamster cells by a tumor promoter. Science 206: 1989–1091

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 1987 Springer-Verlag Berlin Heidelberg

About this paper

Cite this paper

Fischer, S.M. (1987). The Arachidonate Cascade and Mouse Skin Tumor Promotion. In: Garaci, E., Paoletti, R., Santoro, M.G. (eds) Prostaglandins in Cancer Research. Proceedings in Life Sciences. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-71904-2_4

Download citation

  • DOI: https://doi.org/10.1007/978-3-642-71904-2_4

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-642-71906-6

  • Online ISBN: 978-3-642-71904-2

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics